用于预测浆液性卵巢癌患者生存的影像组学-临床列线图的开发
本研究利用1301个静脉期CT影像组学特征构建影像组学标签,并在训练集(TCIA数据库80例)和独立验证集(花都医院39例)中验证。联合影像组学标签与年龄、肿瘤大小、病理分期和肿瘤分级四个临床预测因子构建列线图,训练集C-index为0.754(95%CI 0.678-0.830),验证集为0.727(95%CI 0.569-0.885),高风险与低风险组总生存期有显著差异。
要点
- 基于静脉期CT提取的影像组学标签由3个特征组成,训练集C-index为0.694(95%CI 0.613-0.775),验证集为0.709(95%CI 0.517-0.901)。
- 影像组学-临床列线图包含影像组学标签和年龄、肿瘤大小、病理分期、肿瘤分级4个临床预测因子。
- 列线图将患者分为高风险和低风险组,Kaplan-Meier曲线显示两组总生存期有显著差异。
核心结论
- 所提出的影像组学-临床列线图可提高浆液性卵巢癌患者术后总生存期的预测准确性,可能有助于临床决策。
研究设计与样本
- 回顾性研究,训练集为TCIA数据库80例浆液性卵巢癌患者,独立验证集为花都医院39例符合条件患者;从静脉期CT图像卵巢癌病灶提取1301个影像组学特征,采用LASSO Cox回归构建影像组学标签,基于多变量Cox回归构建列线图。
关键影像表现/征象
- 影像组学标签由3个所选特征组成,在训练集和验证集中均显示良好区分度。
- 列线图包含影像组学标签和年龄、肿瘤大小、病理分期、肿瘤分级4个临床预测因子。
- 根据模型将所有患者分为高风险组和低风险组,Kaplan-Meier曲线显示两组总生存期有显著差异。
诊断标准与关键数值
- 影像组学标签训练集C-index为0.694(95%CI 0.613-0.775),验证集C-index为0.709(95%CI 0.517-0.901)。
- 影像组学-临床列线图训练集C-index为0.754(95%CI 0.678-0.830),验证集C-index为0.727(95%CI 0.569-0.885)。
临床应用与阅片要点
- 作者认为,所提出的影像组学-临床列线图可提高浆液性卵巢癌患者术后总生存期的预测准确性,可能有助于临床决策。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
AIM: To develop and validate a radiomic-clinical nomogram to evaluate overall survival (OS) postoperatively in patients with serous ovarian cancer.
MATERIALS AND METHODS: Eighty serous ovarian cancer patients from The Cancer Imaging Archive (TCIA) database were used as the training set, and 39 eligible patients treated at Affiliated Huadu Hospital were used as the independent validation set. In total, 1,301 radiomics features were extracted from ovarian cancer lesions on venous-phase computed tomography (CT) images. Then, a radiomics signature was developed using the least absolute shrinkage and selection operator (LASSO) Cox regression algorithm in the training set. Moreover, a radiomic-clinical nomogram was constructed incorporating the radiomics signature and clinical predictors based on a multivariable Cox regression analysis. The performance of the nomogram was evaluated.
RESULTS: Consisting of three selected features, the radiomics signature showed good discrimination in the training and validation sets with C-indexes of 0.694 (95% confidence interval [CI]: 0.613-0.775) and 0.709 (95% CI: 0.517-0.901), respectively. The radiomic-clinical nomogram contained the radiomics signature and four clinical predictors, including age, tumour size, pathological staging, and tumour grade. The nomogram showed favourable discrimination in the training set (C-index [95% CI], 0.754 [0.678-0.830]), which was confirmed in the validation set (C-index [95% CI], 0.727 [0.569-0.885]). According to the model, all patients were classified into high-risk and low-risk groups. Kaplan-Meier curves showed that there was a significant distinction between the OS of the high-risk and low-risk patients.
CONCLUSIONS: The proposed radiomic-clinical nomogram can increase the predictive accuracy of OS in patients with serous ovarian cancer after surgery, which may aid in clinical decision-making.
引用
- Hong, Liu, Lin, et al. Development of a radiomic-clinical nomogram for prediction of survival in patients with serous ovarian cancer. Clin Radiol. 2022. PMID: 35264303. doi:10.1016/j.crad.2022.01.038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。